Lung-supporting moxibustion for reducing asthma flare-ups
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether a Traditional Chinese Medicine technique called moxibustion can help reduce asthma attacks and improve control. If you have asthma that is not well managed, this treatment might offer an additional option to ease your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- You must have asthma that is currently stable (not in a sudden attack) but still poorly controlled.
- You must be willing to try moxibustion treatment (a Traditional Chinese Medicine therapy where a herb is burned near the skin) and sign a consent form.
- You cannot have other serious lung diseases like lung abscess, fibrosis, active tuberculosis, or bronchiectasis.
- You cannot have severe heart or brain conditions, severe liver or kidney disease, or be pregnant or breastfeeding.
- You cannot be allergic to the herbs or smoke used in moxibustion, and you must not have had this type of moxibustion in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether acupuncture can improve asthma control in people aged 18 to 70 whose asthma is not well controlled despite their current treatment. It aims to add a non-drug option to help reduce symptoms and improve quality of life.
This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.
This trial tests a new drug called MG-K10 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if the drug can reduce asthma attacks and improve breathing. You may be able to join if you have had asthma for at least a year, use high-dose inhalers plus another controller medicine, and have had a recent flare-up.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests whether adding a traditional Chinese medicine (Liqin Zhike Formula) to standard inhaler treatment (ICS/LABA) helps people with cough variant asthma. It may improve cough control and overall outcomes.
This trial tests if L-menthol can help reduce breathlessness in people with asthma. You'll take L-menthol and see if it improves your breathing during exercise.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.